Aspira Women's Health Inc. is a commercial-stage diagnostics company focused on gynecological disease detection in women. The company develops and markets diagnostic tests including Ova1, Overa, Ova1Plus, OvaWatch, ENDOinform, and OVAinform for ovarian cancer risk assessment, endometriosis, and benign pelvic mass monitoring. Operating through its laboratory subsidiary Aspira Labs, the company also offers the Aspira Synergy platform and Aspira Genetix genetic testing services.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-04-01 | 2025-12-31 | 0000926617-26-000020 | EDGAR | 64K words |
| 2025-03-27 | 2024-12-31 | 0001641172-25-000983 | EDGAR | 68K words |
| 2024-04-01 | 2023-12-31 | 0000926617-24-000015 | EDGAR | 59K words |
| 2023-03-30 | 2022-12-31 | 0000926617-23-000026 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000926617-22-000014 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0000926617-21-000033 | EDGAR | — |
| 2020-04-07 | 2019-12-31 | 0000926617-20-000015 | EDGAR | — |
| 2019-03-28 | 2018-12-31 | 0000926617-19-000007 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0000926617-18-000012 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0000926617-17-000023 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0000926617-26-000054 | EDGAR | 28K words |
| 2025-11-14 | 2025-09-30 | 0000926617-25-000008 | EDGAR | 28K words |
| 2025-08-13 | 2025-06-30 | 0001493152-25-011865 | EDGAR | 28K words |
| 2025-05-19 | 2025-03-31 | 0001641172-25-011399 | EDGAR | 26K words |
| 2024-11-19 | 2024-09-30 | 0001493152-24-046836 | EDGAR | 30K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096220 | EDGAR | 27K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060401 | EDGAR | 23K words |
| 2023-11-13 | 2023-09-30 | 0000926617-23-000095 | EDGAR | 32K words |
| 2023-08-14 | 2023-06-30 | 0000926617-23-000070 | EDGAR | 26K words |
| 2023-05-15 | 2023-03-31 | 0000926617-23-000046 | EDGAR | 21K words |
| 2022-11-10 | 2022-09-30 | 0000926617-22-000058 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000926617-22-000052 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-15 | 0000926617-26-000052 | EDGAR | 15K words |
| 2026-01-30 | 0000926617-26-000007 | EDGAR | 14K words |
| 2025-12-31 | 0000926617-25-000014 | EDGAR | 4K words |
| 2025-12-23 | 0001104659-25-124245 | EDGAR | 20K words |
| 2025-12-22 | 0000926617-25-000010 | EDGAR | 1K words |
| 2025-11-14 | 0000926617-25-000004 | EDGAR | 3K words |
| 2025-10-15 | 0001493152-25-018146 | EDGAR | 0K words |
| 2025-09-25 | 0001493152-25-014925 | EDGAR | 11K words |
| 2025-09-18 | 0001493152-25-013987 | EDGAR | 1K words |
| 2025-09-03 | 0001641172-25-026441 | EDGAR | 6K words |
383 total filings indexed. 351 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000926617 |
| Ticker | AWHL |
| Exchange | OTC |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AWHL (~200 tokens, structured JSON with cryptographic provenance)